Leading oncology centers in the United States engaged to conduct the Phase 2 Antiviral Trial and further advance the development of PUL-042 HOUSTON, TX, UNITED STATES, July 8, 2025 /EINPresswire.com/ ...

With the 2025 influenza season starting earlier than usual, the NICD urges South Africans to stay vigilant against seasonal ...

In young children, the long-term effects of SARS-CoV-2 infection may differ significantly from ... These symptoms were grouped into eight clinical areas: general health, ENT, heart and lungs, ...

Dr Primrose Freestone, a clinical microbiologist from the University of Leicester, says that you should always sit down on ...

Traditionally, COVID vaccines have been delivered via injections. According to the Cincinnati Children’s Hospital Medical ...

Some COVID-19 patients have experienced silent hypoxia, a condition causing low oxygen levels (without obvious symptoms). This condition can be fatal.

In summary, intranasal administration of divalent siRNA N_29293 demonstrated a profound impact on SARS-CoV-2 infection as evidenced by protection from weight loss, decreased viral plaques and viral ...

The North American chitosan market size is anticipated to attain a valuation of USD 11.2 billion in 2023 and is expected to ...

Glucan-mediated trained immunity activates alveolar macrophages which exacerbates acute lung injury induced by LPS.

Infectious disease specialist Monica Gandhi, MD examines recent claims about the safety of thimerosal, a preservative used in ...

Latest medical research on lung disease. Learn about the symptoms of chronic obstructive pulmonary disease (COPD), emphysema, and lung cancer along with the latest treatment information.